Pathologic Calcification (Dystrophic vs Metastatic)

Pathologic calcification is the abnormal deposition of calcium salts in tissues, and it comes in two flavors that USMLE Step 1 loves to distinguish: dystrophic and metastatic. The core distinction is simple but easy to blur under pressure — dystrophic happens in dead or damaged tissue with normal serum calcium, while metastatic happens in normal tissue because serum calcium is elevated. Get that framework locked in first, because the exam will try to trip you up by mixing the terminology. The third testable piece here is psammoma bodies, which are a specific microscopic finding tied to a short list of tumors you need to memorize cold.

Step 1 tests this concept from multiple angles. Straightforward recall questions ask you to classify a scenario as dystrophic vs metastatic based on the clinical context — is the patient hypercalcemic or not? Does the tissue have a history of injury? Application questions give you a pathology description (say, calcification in an atherosclerotic plaque or a caseous necrosis granuloma) and ask you to identify the type. Passage-based questions might describe a tumor with characteristic 'laminated calcifications' on histology and expect you to name the tumor. The exam is testing whether you understand the mechanism, not just the label.

The biggest trap here is the word 'metastatic.' Students hear it and immediately think cancer spreading to other organs — that is the wrong mental model entirely. Metastatic calcification has zero relationship to metastatic cancer. It's named for the concept of calcium 'metastasizing' (spreading) to distant normal tissues due to a systemic calcium problem. Similarly, students often assume dystrophic calcification must involve some calcium abnormality — it doesn't. Normal serum calcium, damaged tissue, local calcification. That's the whole story.